InvestorsHub Logo
Followers 32
Posts 4233
Boards Moderated 0
Alias Born 07/25/2007

Re: LongRun8 post# 3030

Friday, 07/26/2024 2:39:53 PM

Friday, July 26, 2024 2:39:53 PM

Post# of 3181

Paxlovid comes up short again...

https://www.nejm.org/doi/full/10.1056/NEJMoa2309002

Oral Nirmatrelvir–Ritonavir as Postexposure Prophylaxis for Covid-19



This would seem to provide an opening for a partnership for ENTA's anti-Covid protease inhibitor EDP-235. I won't be holding my breath but it sure would be nice for ENTA shareholders.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENTA News